{"text": ["Bristol", "To", "Become", "Top", "5", "Pharma", "\u2014", "And", "Other", "Fallout", "From", "Celgene", "Takeover"], "created_at": "2019-01-04 21:24:40"}
{"text": ["Pharma", "Stock", "Roundup:", "BMY", "to", "Buy", "CELG", "for", "$74B,", "MRK", "Gets", "Rights", "to", "NASH", "Candidate"], "created_at": "2019-01-04 17:11:53"}
{"text": ["Pharma", "Stock", "Roundup:", "BMY", "to", "Buy", "CELG", "for", "$74B,", "MRK", "Gets", "Rights", "to", "NASH", "Candidate"], "created_at": "2019-01-04 17:11:53"}
{"text": ["Nektar,", "ImaginAb", "Enter", "Into", "Immuno-Oncology", "Collaboration"], "created_at": "2019-01-04 15:08:51"}
{"text": ["Nektar,", "ImaginAb", "Enter", "Into", "Immuno-Oncology", "Collaboration"], "created_at": "2019-01-04 15:08:51"}
{"text": ["Pharma", "Stock", "Roundup:", "BMY", "to", "Buy", "CELG", "for", "$74B,", "MRK", "Gets", "Rights", "to", "NASH", "Candidate"], "created_at": "2019-01-04 15:07:03"}
{"text": ["Health", "Care", "Sector", "Update", "for", "01/04/2019:", "FLKS,", "NVAX,", "ESPR,", "JNJ,", "PFE,", "ABT,", "MRK,", "AMGN"], "created_at": "2019-01-04 14:27:19"}
{"text": ["Health", "Care", "Sector", "Update", "for", "01/04/2019:", "FLKS,", "NVAX,", "ESPR,", "JNJ,", "PFE,", "ABT,", "MRK,", "AMGN"], "created_at": "2019-01-04 14:27:19"}
{"text": ["Pfizer", "Begins", "Pivotal", "Study", "on", "Alopecia", "Areata", "Candidate"], "created_at": "2019-01-04 14:11:01"}
{"text": ["Pfizer", "Begins", "Pivotal", "Study", "on", "Alopecia", "Areata", "Candidate"], "created_at": "2019-01-04 14:11:01"}
{"text": ["Pfizer", "Rises", "3%"], "created_at": "2019-01-04 13:06:02"}
{"text": ["Pfizer", "Begins", "Pivotal", "Study", "on", "Alopecia", "Areata", "Candidate"], "created_at": "2019-01-04 12:29:12"}
{"text": ["Today's", "Research", "Reports", "on", "Trending", "Tickers:", "Pfizer", "and", "Bristol-Myers", "Squibb"], "created_at": "2019-01-04 11:50:00"}
